71 Recruiting Hodgkin Lymphoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Hodgkin Lymphoma
Related Conditions
Top Recruiting Hodgkin Lymphoma Studies
Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
📍 Karmanos Cancer Institute — Detroit, Michigan
View Study & Checklist ➔Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
📍 Children's Hospital of Alabama ( Site 0023) — Birmingham, Alabama
View Study & Checklist ➔PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
📍 Utah University School of Medicine/Huntsman Cancer Institute — Salt Lake City, Utah
View Study & Checklist ➔A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
📍 Karmanos Cancer Institute — Detroit, Michigan
View Study & Checklist ➔Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL
📍 University of Chicago Medicine — Chicago, Illinois
View Study & Checklist ➔Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL
📍 Houston Methodist Hospital — Houston, Texas
View Study & Checklist ➔Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma
📍 Packard Children's Hospital, Stanford University — Palo Alto, California
View Study & Checklist ➔Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
View Study & Checklist ➔Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
📍 University of Illinois Cancer Center — Chicago, Illinois
View Study & Checklist ➔A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
📍 City of Hope Cancer Center (Data Collection Only) — Duarte, California
View Study & Checklist ➔Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
📍 Concord Repatriation General Hospital — Concord, New South Wales
View Study & Checklist ➔Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma
📍 Hospital Regional Alta Especialidad Bajio — León, Guanajuato
View Study & Checklist ➔A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
📍 Stanford University - (Stanford Cancer Institute) — Stanford, California
View Study & Checklist ➔BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
📍 UT MD Anderson — Houston, Texas
View Study & Checklist ➔